Cardiospire is a United States-based startup established in 2015 with the mission of providing non-invasive hemodynamic monitoring solutions in the Health Care and Medical Devices industries. The company recently secured a Convertible Note investment in November 2020, with IT-Farm Corporation participating as the investor.
Cardiospire
Non-invasive hemodynamic monitoring
Founded 2015
San Francisco, United States
4 employees
Convertible Note
Total: $2.80M
Health Care, Medical Devices
San Francisco, United States
4 employees
Convertible Note
Total: $2.80M
Health Care, Medical Devices
General Information
Company Name
Cardiospire
Founded Year
2015
Location
San Francisco, United States
San Francisco, United States
Employees
4
Industries
Health Care, Medical Devices
Funding Stage
Convertible Note
BounceWatch is an independent company data service, not affiliated with Cardiospire. To contact Cardiospire, visit respirix.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Cardiospire compare?
A PDF of Cardiospire and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Cardiospire soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Health Care
About Cardiospire
Business keywords: digital health, hemodynamic monitoring, pulmonary vasculature, health software, health hardware, at-home monitoring, critical care applications, heart failure, non-invasive, healthcare analytics, patient monitoring, cardiovascular health, health insights
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Convertible Note | Undisclosed | 1 |
|
20 Nov 2020 |
| Debt Financing | $1.30M | - |
|
14 Aug 2019 |
| Seed Round | Undisclosed | 2 |
|
17 Jun 2019 |
| Convertible Note | $1.50M | 2 |
|
01 Feb 2016 |
Cardiospire Alternatives & Competitors
View All Alternatives
Cardiospire vs
Sensydia Corporation
United States
Advancing cardiovascular care with non-invasive, point-of-care hemodynamic measurement.
Grant
7 employees
AI, Hardware
Cardiospire vs
Vixiar Medical
United States
Developing non-invasive devices and systems for monitoring cardiopulmonary diseases.
Series A
8 employees
Biotechnology, Health Care
Cardiospire vs
Caretaker Medical | Wireless Hemodynamic Monitoring
United States
Wireless, Continuous, Simple, Hemodynamic Monitoring at all points of care.
Series C
84 employees
Health Care, Medical Devices
Flosonics Medical
FAQ About Cardiospire
Non-invasive hemodynamic monitoring
Cardiospire was founded in 2015.
Cardiospire is headquartered in San Francisco, United States.
Cardiospire operates in Health Care and Medical Devices. Its work centres on digital health, hemodynamic monitoring, pulmonary vasculature and health software.
Cardiospire has approximately 4 employees.
Cardiospire has completed 4 funding rounds, raising a total of $2.80M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Cardiospire include Sensydia Corporation, Vixiar Medical, Caretaker Medical | Wireless Hemodynamic Monitoring, Remon Medical Technologies, Flosonics Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cardiospire and Sensydia Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Cardiospire, https://bouncewatch.com/company/cardiospire, updated 10 October 2024. When citing, please name BounceWatch and link this page.
